Mary Spellman

Mary Spellman, M.D., is Chief Medical Officer and Senior Vice President of Research & Development of Castle Creek Biosciences, Inc. Dr. Spellman is a board‑certified dermatologist with more than 30 years of clinical research experience. She directed the clinical research group in dermatology at the University of California, San Diego and has held various leadership positions in research and development at Menlo Therapeutics, Revance Therapeutics, Biogen Idec, Connetics Corporation, and Novartis. Dr. Spellman earned an M.D. from the Medical College of Wisconsin and is a diplomate of the American Board of Dermatology and a fellow of the American Academy of Dermatology.